Novartis' Beovu Approved by NMPA for Diabetic Macular Edema Treatment
CompanyDrug

Novartis’ Beovu Approved by NMPA for Diabetic Macular Edema Treatment

Mabworks' MIL62 Gains NMPA Review for NMOSD Treatment
CompanyDrug

Mabworks’ MIL62 Gains NMPA Review for NMOSD Treatment

EpimAb Biotherapeutics and Juri Biosciences Ink Global Licensing Deal for KLK2-CD3 T-Cell Engager
CompanyDeals

EpimAb Biotherapeutics and Juri Biosciences Ink Global Licensing Deal for KLK2-CD3 T-Cell Engager

Eli Lilly to Acquire SiteOne Therapeutics for Up to USD 1 Billion
CompanyDeals

Eli Lilly to Acquire SiteOne Therapeutics for Up to USD 1 Billion

Junshi Biosciences' Junshida Wins NMPA Approval for HeFH and Statin-Intolerant Patients
CompanyDrug

Junshi Biosciences’ Junshida Wins NMPA Approval for HeFH and Statin-Intolerant Patients

Sino Biopharmaceutical Presents TQB2102 Phase I Results at ASCO 2025
CompanyDrug

Sino Biopharmaceutical Presents TQB2102 Phase I Results at ASCO 2025

BeiGene Rebrands to BeOne Medicines and Relocates to Switzerland
Company

BeiGene Rebrands to BeOne Medicines and Relocates to Switzerland

Betta Pharmaceuticals Partners with BioRay for Herceptin Biosimilar Anruize
CompanyDeals

Betta Pharmaceuticals Partners with BioRay for Herceptin Biosimilar Anruize

China's NMPA Approves Lifetech's Aortic Fenestration Stent System
CompanyMedical Device

China’s NMPA Approves Lifetech’s Aortic Fenestration Stent System

Phanes Therapeutics Doses First Patient in CD73 Antibody Clinical Study
CompanyDrug

Phanes Therapeutics Doses First Patient in CD73 Antibody Clinical Study

StarryGene Initiates Phase II Study of XMVA09 for Wet AMD Treatment
CompanyDrug

StarryGene Initiates Phase II Study of XMVA09 for Wet AMD Treatment

Sinotau Pharma Files for HK IPO Focused on Radiopharmaceutical Pipeline
CompanyDeals

Sinotau Pharma Files for HK IPO Focused on Radiopharmaceutical Pipeline